SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-055677
Filing Date
2013-10-17
Accepted
2013-10-17 21:31:04
Documents
1
Period of Report
2013-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 v357525_4.html 4  
1 FORM 4 v357525_4.xml 4 4109
  Complete submission text file 0001144204-13-055677.txt   5445
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENEXTRA S.P.A. VIA G. DE GRASSI, 11 MILAN L6 20124
Business Address
Micheli Francesco (Reporting) CIK: 0001569222 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 131158092